Cargando…

FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab

BACKGROUND: Polymorphisms of genes encoding the Fcy receptors (Fc fragment of IgG receptor 2A (FCGR2A) and 3A (FCGR3A)), which influence their affinity for the Fc fragment, have been linked to the pharmacodynamics of monoclonal antibodies. Most studies have been limited by small samples sizes and ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kjersem, Janne B, Skovlund, Eva, Ikdahl, Tone, Guren, Tormod, Kersten, Christian, Dalsgaard, Astrid M, Yilmaz, Mette K, Fokstuen, Tone, Tveit, Kjell M, Kure, Elin H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045863/ https://www.ncbi.nlm.nih.gov/pubmed/24884501 http://dx.doi.org/10.1186/1471-2407-14-340

Ejemplares similares

Let-7 miRNA-binding site polymorphism in the KRAS 3(′)UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/− cetuximab
por: Kjersem, Janne B, et al.
Publicado: (2012)

Plasma YKL-40 in Patients with Metastatic Colorectal Cancer Treated with First Line Oxaliplatin-Based Regimen with or without Cetuximab: RESULTS from the NORDIC VII Study
por: Tarpgaard, Line S., et al.
Publicado: (2014)

Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer
por: Thomsen, Maria, et al.
Publicado: (2016)

Association of FCGR2A and FCGR2A-FCGR3A haplotypes with susceptibility to giant cell arteritis
por: Morgan, Ann W, et al.
Publicado: (2006)

Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab
por: Magnes, T., et al.
Publicado: (2019)

Association of FCGR3A and FCGR3B haplotypes with rheumatoid arthritis and primary Sjögren's syndrome
por: Mackie, S, et al.
Publicado: (2005)

FCGR2A and FCGR3A Genotypes in Human Immunodeficiency Virus Mother-to-Child Transmission
por: Milligan, Caitlin, et al.
Publicado: (2015)

Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study
por: Guren, Tormod Kyrre, et al.
Publicado: (2017)

Association of FCGR2A/FCGR3A variant rs2099684 with Takayasu arteritis in the Han Chinese population
por: Chen, Si, et al.
Publicado: (2016)

FCGR2A, FCGR3A polymorphisms and therapeutic efficacy of anti-EGFR monoclonal antibody in metastatic colorectal cancer
por: Ying, Hou-Qun, et al.
Publicado: (2015)

FCGR3A and FCGR2A Genotypes Differentially Impact Allograft Rejection and Patients' Survival After Lung Transplant
por: Paul, Pascale, et al.
Publicado: (2019)

Association of FCGR3A and FCGR3B Copy Number Variations With Systemic Lupus Erythematosus and Rheumatoid Arthritis in Taiwanese Patients
por: Chen, Ji-Yih, et al.
Publicado: (2014)

Influence of the FCGR2A rs1801274 and FCGR3A rs396991 Polymorphisms on Response to Abatacept in Patients with Rheumatoid Arthritis
por: Márquez Pete, Noelia, et al.
Publicado: (2021)

Copy number variation of FCGR genes in etiopathogenesis of sarcoidosis
por: Typiak, Marlena, et al.
Publicado: (2017)

Single Nucleotide Polymorphism rs10919543 in FCGR2A/FCGR3A Region Confers Susceptibility to Takayasu Arteritis in Chinese Population
por: Qin, Fang, et al.
Publicado: (2016)

Messenger RNA of FCGR3A and FCGR3B Genes as Monitoring Markers of Clear Cell Renal Adenocarcinoma (a Pilot Study)
por: Alyasova, A.V., et al.
Publicado: (2022)

A Comparison of Assays for Accurate Copy Number Measurement of the Low-Affinity Fc Gamma Receptor Genes FCGR3A and FCGR3B
por: Haridan, Umi Shakina, et al.
Publicado: (2015)

CNVrd, a Read-Depth Algorithm for Assigning Copy-Number at the FCGR Locus: Population-Specific Tagging of Copy Number Variation at FCGR3B
por: Nguyen, Hoang tan, et al.
Publicado: (2013)

Copy number, linkage disequilibrium and disease association in the FCGR locus
por: Niederer, Heather A., et al.
Publicado: (2010)

Frequency of FCGR3B Alleles in Thai Blood Donors
por: Kaset, Chollanot, et al.
Publicado: (2013)

Polymorphism of FCGR3A gene in chronic beryllium disease
por: Liu, Bing, et al.
Publicado: (2018)

Comparative Analysis of FCGR Gene Polymorphism in Pulmonary Sarcoidosis and Tuberculosis
por: Typiak, Marlena, et al.
Publicado: (2023)

Fluorouracil/folinic acid/oxaliplatin: Various toxicities: 2 case reports
Publicado: (2021)

Associations of Fc gamma receptor (FcgR2a, FcgR3a and FcgR2c) genotype with outcome in metastatic renal cell carcinoma (mRCC) patients receiving high dose interleukin 2 (HD-IL2)
por: Erbe, Amy K, et al.
Publicado: (2015)

Differential Expression of miRNAs in Colorectal Cancer: Comparison of Paired Tumor Tissue and Adjacent Normal Mucosa Using High-Throughput Sequencing
por: Hamfjord, Julian, et al.
Publicado: (2012)

Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer
por: Mezheyeuski, Artur, et al.
Publicado: (2016)

Protective effects of FCGR2A polymorphism in invasive pneumococcal diseases
por: Bouglé, A, et al.
Publicado: (2012)

Alignment-free genomic sequence comparison using FCGR and signal processing
por: Lichtblau, Daniel
Publicado: (2019)

FCGR2C: An emerging immune gene for predicting sepsis outcome
por: Liu, Si, et al.
Publicado: (2022)

Analysis of Fcγ receptor haplotypes in rheumatoid arthritis: FCGR3A remains a major susceptibility gene at this locus, with an additional contribution from FCGR3B
por: Morgan, Ann W, et al.
Publicado: (2006)

FCGR2B and FCRLB Gene Polymorphisms Associated with IgA Nephropathy
por: Zhou, Xu-jie, et al.
Publicado: (2013)

Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancer
por: Conroy, T, et al.
Publicado: (2008)

TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: A potential novel approach to the treatment of metastatic colorectal cancer
por: Tarpgaard, Line S., et al.
Publicado: (2016)

FCGR3A: A new biomarker with potential prognostic value for prostate cancer
por: Zha, Zeyu, et al.
Publicado: (2022)

Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome
por: Thomsen, Maria, et al.
Publicado: (2018)

Impact of the oxaliplatin-5 fluorouracil-folinic acid combination on respective intracellular determinants of drug activity
por: Fischel, J L, et al.
Publicado: (2002)

Survival Trends of Right- and Left-Sided Colon Cancer across Four Decades: A Norwegian Population-Based Study
por: Hamfjord, Julian, et al.
Publicado: (2022)

High Affinity Allele for the Gene of FCGR3A Is Risk Factor for HIV Infection and Progression
por: Poonia, Bhawna, et al.
Publicado: (2010)

FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease
por: Kuo, Ho-Chang, et al.
Publicado: (2015)

Assessment of the Clinical Heterogeneity of Kawasaki Disease Using Genetic Variants of BLK and FCGR2A
por: Sim, Bo Kyung, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_eetr3hhnthvkt20tpc80qj0qc1